首页> 美国卫生研究院文献>Nucleic Acids Research >Characterization of the DNA-binding domain and identification of the active site residue in the ‘Gyr A’ half of Leishmania donovani topoisomerase II
【2h】

Characterization of the DNA-binding domain and identification of the active site residue in the ‘Gyr A’ half of Leishmania donovani topoisomerase II

机译:利什曼原虫donovani拓扑异构酶II的 Gyr A半部中DNA结合域的表征和活性位点残基的鉴定

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

DNA topoisomerase II is a multidomain homodimeric enzyme that changes DNA topology by coupling ATP hydrolysis to the transport of one DNA helix through a transient double-stranded break in another. To investigate the biochemical properties of the individual domains of Leishmania donovani topoisomerase II, four truncation mutants were generated. Deletion of 178 aminoacids from the C-terminus (core and LdΔC1058) had no apparent effect on the DNA-binding or cleavage activities of the enzymes. However, when 429 aminoacids from the N-terminus and 451 aminoacids from the C-terminus were removed (LdΔNΔC), the enzyme was no longer active. Moreover, the removal of 429 aminoacids from the N-terminus (LdΔNΔC, core and LdΔN429) render the mutant proteins incapable of performing ATP hydrolysis. The mutant proteins show cleavage activities at wide range of KCl concentrations (25–350 mM). In addition, the mutant proteins, excepting LdΔNΔC, can also act on kDNA and linearize the minicircles. Surprisingly, the mutant proteins fail to show the formation of the enhanced cleavable complex in the presence of etoposide. Our findings suggest that the conformation required for interaction with the drug is absent in the mutant proteins. Here, we have also identified Tyr775 through direct sequencing of the DNA linked peptide as the catalytic residue implicated in DNA-breakage and rejoining. Taken together, our results demonstrate that topoisomerase II are functionally and mechanistically conserved enzymes and the variations in activity seem to reflect functional optimization for its physiological role during parasite genome replication.
机译:DNA拓扑异构酶II是一种多域同型二聚体酶,通过将ATP水解偶联到一个DNA螺旋的转运中,通过另一个瞬时的双链断裂来改变DNA拓扑。为了研究利什曼原虫多诺万拓扑异构酶II的各个域的生化特性,生成了四个截断突变体。从C末端(核心和LdΔC1058)删除178个氨基酸对酶的DNA结合或切割活性没有明显影响。但是,当去除了来自N端的429个氨基酸和来自C端的451个氨基酸时(LdΔNΔC),该酶不再具有活性。此外,从N末端(LdΔNΔC,核心和LdΔN429)除去429个氨基酸使突变蛋白无法进行ATP水解。突变蛋白在宽范围的KCl浓度(25–350 mM)下显示出裂解活性。此外,除LdΔNΔC外,突变蛋白也可以作用于kDNA并使线性微环线性化。出人意料的是,在依托泊苷存在下,突变蛋白未能显示出增强的可切割复合物的形成。我们的发现表明突变蛋白中缺少与药物相互作用所需的构象。在这里,我们还通过对DNA连接肽的直接测序鉴定了Tyr 775 ,这是与DNA断裂和重新结合有关的催化残基。两者合计,我们的结果表明,拓扑异构酶II是功能和机械上保守的酶,活性的变化似乎反映了寄生虫基因组复制过程中对其生理作用的功能优化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号